ARO-C3 is an investigational RNA interference therapeutic designed to reduce liver production of complement component 3 as a potential therapy for various complement-mediated diseases.

(HealthDay News) — Wildfire smoke exposure over time may increase the risk for heart failure, according to a study published in the July issue of the Journal of the American College of Cardiology.

However, incidence rates of vision-threatening diabetic retinopathy, diabetic macular edema, and proliferative diabetic retinopathy have decreased.

An elderly man with immunoglobulin G4-related disease (IgG4-RD) with kidney involvement and monoclonal gammopathy was successfully treated with corticosteroid therapy. This case report was published ...

Most individuals with chronic kidney disease (CKD) are unaware of their disease, according to a KDIGO controversies conference on CKD prevention.

Delirium most common among those with intracerebral hemorrhage; more severe delirium tied to worse outcomes. (HealthDay News) — More than one in four critically ill patients with stroke experience ...

(HealthDay News) — Fecal microbiota analysis of pregnant women may provide early identification of those at risk for gestational diabetes, according to a study published online July 1 in Microbiology ...

Investigators studied recent trends in chain ownership, physician ownership, and medical directorship of dialysis facilities in the US.